Previous 10 | Next 10 |
Fortress Biotech (NASDAQ: FBIO ) announces that Caelum Biosciences in collaboration with Alexion Pharmaceuticals (NASDAQ: ALXN ) have initiated the Cardiac Amyloid Reaching for Extended Survival (CARES) Phase 3 clinical program to evaluate CAEL-101, an amyloid fibril targeted therapy, ...
- Phase 2 study met primary objective, supporting initiation of two parallel Phase 3 studies that will enroll ~370 AL amyloidosis patients - - Positive long-term Phase 1a/1b data presented at the International Symposium on Amyloidosis (ISA) 2020 demonstrate prolonged overall survival (...
Alexion Pharmaceuticals (Nasdaq:ALXN) a biotechnology company focused in rare disease development and commercialization, today announced that the company will host a Virtual Investor Day on Tuesday, October 6th, 2020 from 8:00 a.m. to 12:00 p.m. ET. Management will highlight continued strateg...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead A full slate of investor conferences and updates in the week ahead will include presentations by e...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
It's been a painful week for growth investors given significant declines in technology-oriented indexes and exchange traded funds. The NASDAQ 100 ETF ( QQQ ) fell over 11% from its intraday high this month to its intraday low this week, and returns were worse for software investors given the...
- Accepted abstracts include data assessing the long-term efficacy and safety of SOLIRIS ® (eculizumab) in neuromyelitis optica spectrum disorder (NMOSD) - - Data from 11 abstracts demonstrate Alexion’s commitment to continuing to advance the understanding of the bur...
Every year since 1894, the first Monday in September has been a federally recognized holiday to "celebrate the social and economic achievements of American workers," according to the U.S. Department of Labor. However, Labor Day has taken on a completely different feel in 2020. The coronav...
The SPDR S&P 500 Trust ETF ( SPY ) is tumbling following a massive rally that's taken a few breathers since March isn't surprising. Our service's sentiment indicator has been flashing warning signs for weeks, prompting us to highlight the risk of a pending market drop here and here. ...
Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that management will present at the following upcoming investor conferences: Citi’s 15 th Annual BioPharma Conference, taking place virtually on Thursday, September 10 th , 2020 at 10:45 a.m. ET. Morgan Stanley’s 1...
News, Short Squeeze, Breakout and More Instantly...
Alexion Pharmaceuticals Inc. Company Name:
ALXN Stock Symbol:
NASDAQ Market:
Alexion Pharmaceuticals Inc. Website:
AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...
This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...